These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 33644656)
1. Refractory constrictive pericarditis caused by an immune checkpoint inhibitor properly managed with infliximab: a case report. Moriyama S; Fukata M; Tatsumoto R; Kono M Eur Heart J Case Rep; 2021 Jan; 5(1):ytab002. PubMed ID: 33644656 [TBL] [Abstract][Full Text] [Related]
2. A case of effusive-constrictive pericarditis accompanying rheumatoid arthritis: The possibility of adverse effect of TNF-inhibitor therapy. Nakamura Y; Izumi C; Nakagawa Y; Hatta K J Cardiol Cases; 2013 Jan; 7(1):e8-e10. PubMed ID: 30533107 [TBL] [Abstract][Full Text] [Related]
3. Recurrent Pericardial Effusion in a Patient With Delayed Progression of Melanoma Treated With Immune Checkpoint Inhibitors. Valencia EA; Anumolu N; Jha P Cureus; 2023 Oct; 15(10):e47727. PubMed ID: 38021498 [TBL] [Abstract][Full Text] [Related]
4. Breaking hearts and taking names: A case of sarcoidosis related effusive-constrictive pericarditis. Valentin R; Keeley EC; Ataya A; Gomez-Manjarres D; Petersen J; Arnaoutakis GJ; Drew P; Barnes M; Patel DC Respir Med; 2020 Mar; 163():105879. PubMed ID: 32056834 [TBL] [Abstract][Full Text] [Related]
5. "Pericardial flare" associated with immunoglobulin G4-related disease: A case report - rapid transition from cardiac tamponade to effusive constrictive pericarditis. Fujita H; Matsumoto K; Miwa K; Hirata KI J Cardiol Cases; 2021 Jul; 24(1):37-40. PubMed ID: 34257760 [TBL] [Abstract][Full Text] [Related]
6. Acute liver injury in the context of immune checkpoint inhibitor-related colitis treated with infliximab. Zhang HC; Luo W; Wang Y J Immunother Cancer; 2019 Feb; 7(1):47. PubMed ID: 30777137 [TBL] [Abstract][Full Text] [Related]
7. Constrictive pericarditis after heart transplantation: a case report. Tchana-Sato V; Ancion A; Ansart F; Defraigne JO Eur Heart J Case Rep; 2020 Aug; 4(4):1-6. PubMed ID: 32974473 [TBL] [Abstract][Full Text] [Related]
8. [Management of pericarditis and pericardial effusion, constrictive and effusive-constrictive pericarditis]. Maisch B Herz; 2018 Nov; 43(7):663-678. PubMed ID: 30315402 [TBL] [Abstract][Full Text] [Related]
9. Blunt trauma as a suspected cause of delayed constrictive pericarditis: a case report. Anderson EM; Jaroszewski DE; Arabia FA J Med Case Rep; 2011 Feb; 5():76. PubMed ID: 21345214 [TBL] [Abstract][Full Text] [Related]
10. Real-World Clinical and Economic Outcomes in Selected Immune-Related Adverse Events Among Patients with Cancer Receiving Immune Checkpoint Inhibitors. Zheng Y; Kim R; Yu T; Gayle JA; Wassel CL; Dreyfus J; Phatak H; George S Oncologist; 2021 Nov; 26(11):e2002-e2012. PubMed ID: 34327774 [TBL] [Abstract][Full Text] [Related]
11. Association of Immune-Related Adverse Events with Clinical Benefit in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab. Toi Y; Sugawara S; Kawashima Y; Aiba T; Kawana S; Saito R; Tsurumi K; Suzuki K; Shimizu H; Sugisaka J; Ono H; Domeki Y; Terayama K; Nakamura A; Yamanda S; Kimura Y; Honda Y Oncologist; 2018 Nov; 23(11):1358-1365. PubMed ID: 29934411 [TBL] [Abstract][Full Text] [Related]
12. Nivolumab-induced synovitis is characterized by florid T cell infiltration and rapid resolution with synovial biopsy-guided therapy. Murray-Brown W; Wilsdon TD; Weedon H; Proudman S; Sukumaran S; Klebe S; Walker JG; Smith MD; Wechalekar MD J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32571993 [TBL] [Abstract][Full Text] [Related]
13. Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors. Nuzzo PV; Pond GR; Abou Alaiwi S; Nassar AH; Flippot R; Curran C; Kilbridge KL; Wei XX; McGregor BA; Choueiri T; Harshman LC; Sonpavde G J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32234849 [TBL] [Abstract][Full Text] [Related]
14. [A case of tuberculous pericarditis developing constrictive pericarditis]. Mizutani H; Horiba M; Shindoh J; Kimura T; Son M; Wakahara K Kekkaku; 2001 Feb; 76(2):71-5. PubMed ID: 11260927 [TBL] [Abstract][Full Text] [Related]
15. Management of Steroid-Refractory Gastrointestinal Immune-Related Adverse Events. Brongiel S; Rychalsky KL; Luon D; Johnson AR; Price C; Abdelghany O Ann Pharmacother; 2023 Feb; 57(2):148-155. PubMed ID: 35656843 [TBL] [Abstract][Full Text] [Related]
16. An autopsy case of lung adenocarcinoma with immune checkpoint inhibitor-induced pneumonia and fulminant myocarditis following pembrolizumab administration: a case report. Hashimoto T; Takahashi K; Ito K; Iwade K; Torii A; Sugihara M; Kondo H; Hara T Int Cancer Conf J; 2024 Jul; 13(3):218-222. PubMed ID: 38962041 [TBL] [Abstract][Full Text] [Related]
17. [Constrictive Pericarditis Associated with Pericardial Hematoma:Report of a Case]. Miyamoto K; Onitsuka H Kyobu Geka; 2021 Dec; 74(13):1101-1105. PubMed ID: 34876541 [TBL] [Abstract][Full Text] [Related]
18. Misdiagnosis of constrictive pericarditis presenting with haemorrhagic pericardial effusion: a case report. Li G; Liu P; Li D; Yan Y Eur Heart J Case Rep; 2019 Jun; 3(2):. PubMed ID: 31449622 [TBL] [Abstract][Full Text] [Related]